EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Informed consent in radiotherapy: lessons from Italian case law for daily clinical practice

Micaela Motta, Gokoulakrichenane Loganadane, Rita De Sanctis, Daniela Alterio, Alessandra Cocchi, Agostina De Stefani, Laura Lozza, Albina Allajbej, Davide Franceschini, Antonio Laudati, Federica Piccolo, Davide Tomasini, Francesca Bettoni, Eleonora Burgazzi, Ilaria Albanese, Dimitri Anzellini, Stefano Arcangeli

Recenti Progressi in Medicina · 2026-11-01 · 117 (11)

DOI: 10.1701/4802.48275 ↗
AbstractBibliografische Angaben

Abstract

Summary. Background. Informed consent is a fundamental paradigm in medicine, yet radiotherapy presents unique challenges due to technical complexity and delayed side effects. Following Italian Law 219/2017, consent has evolved into a constitutional right. This study analyzes recent Italian case law to synthesize evidence-based recommendations for clinical radiotherapy practice. Methods. A qualitative, doctrinal legal research design examined judicial decisions from 2017 to 2025. Records were retrieved from Italian judicial databases using keywords including “informed consent” and “radiotherapy”. Inclusion criteria focused on radiotherapy procedures, consent disputes, and detailed judicial reasoning. Results. Eight court decisions and one guideline met inclusion criteria, revealing a shift from contractual obligation to a constitutional right (Articles 2, 13, and 32). Courts established a dual liability framework: “self-determination violation” (automatic liability for failure to inform) and “health damage” (requiring proof the patient would have refused treatment). Disclosure obligations now strictly mandate discussing late effects, rare complications, and alternatives. Notably, in one case failure to discuss surgical alternatives resulted in significant financial damages. Conclusions. Compliance now prioritizes clear communication and verification of patient comprehension over mere form-signing. To mitigate liability and protect rights, oncologists must enhance disclosure regarding late toxicities and treatment alternatives.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →